Inhibition of RNA-binding proteins with small molecules

P Wu - Nature Reviews Chemistry, 2020 - nature.com
Protein–RNA interactions have crucial roles in various cellular activities, which, when
dysregulated, can lead to a range of human diseases. The identification of small molecules …

RNA-binding proteins in cancer drug discovery

JB Bertoldo, S Müller, S Hüttelmaier - Drug discovery today, 2023 - Elsevier
Highlights•RNA-binding proteins (RBPs) are essential for tumorigenesis, immune evasion,
invasion, migration and metastasis, hence promising drug targets in cancer therapy.•Small …

A review of FDA-approved anti-HIV-1 drugs, anti-gag compounds, and potential strategies for HIV-1 eradication

B Sever, M Otsuka, M Fujita, H Ciftci - International Journal of Molecular …, 2024 - mdpi.com
Acquired immunodeficiency syndrome (AIDS) is an enormous global health threat stemming
from human immunodeficiency virus (HIV-1) infection. Up to now, the tremendous advances …

HIV genome-wide protein associations: a review of 30 years of research

G Li, E De Clercq - Microbiology and Molecular Biology Reviews, 2016 - journals.asm.org
The HIV genome encodes a small number of viral proteins (ie, 16), invariably establishing
cooperative associations among HIV proteins and between HIV and host proteins, to invade …

Targeting rna‐binding proteins with small molecules: perspectives, pitfalls and bifunctional molecules

Q Li, C Kang - FEBS letters, 2023 - Wiley Online Library
RNA‐binding proteins (RBPs) play vital roles in organisms through binding with RNAs to
regulate their functions. Small molecules affecting the function of RBPs have been …

Analysis of HIV-1 matrix-envelope cytoplasmic tail interactions

A Alfadhli, AO Staubus, PR Tedbury… - Journal of …, 2019 - journals.asm.org
The matrix (MA) domains of HIV-1 precursor Gag (PrGag) proteins direct PrGag proteins to
plasma membrane (PM) assembly sites where envelope (Env) protein trimers are …

The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target

JJ Madara, Z Han, G Ruthel, BD Freedman… - Future …, 2015 - Taylor & Francis
The highly virulent nature of Ebola virus, evident from the 2014 West African pandemic,
highlights the need to develop vaccines or therapeutic agents that limit the pathogenesis …

Analysis of HIV-1 Gag protein interactions via biotin ligase tagging

C Ritchie, I Cylinder, EJ Platt, E Barklis - Journal of virology, 2015 - journals.asm.org
We have examined the interactions of wild-type (WT) and matrix protein-deleted (ΔMA) HIV-
1 precursor Gag (PrGag) proteins in virus-producing cells using a biotin ligase-tagging …

Functional conservation of HIV-1 Gag: implications for rational drug design

G Li, J Verheyen, SY Rhee, A Voet, AM Vandamme… - Retrovirology, 2013 - Springer
Background HIV-1 replication can be successfully blocked by targeting gag gene products,
offering a promising strategy for new drug classes that complement current HIV-1 treatment …

Screening approaches for targeting ribonucleoprotein complexes: a new dimension for drug discovery

VG D'Agostino, D Sighel, C Zucal… - … Life Sciences R&D, 2019 - journals.sagepub.com
RNA-binding proteins (RBPs) are pleiotropic factors that control the processing and
functional compartmentalization of transcripts by binding primarily to mRNA untranslated …